Effects of morphine and pentazocine on the turnover of noradrenaline and dopamine in various regions of the rat brain.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D008526:Medulla Oblongata / Q000378:metabolism; D008781:Methyltyrosines / Q000494:pharmacology; D009020:Morphine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010423:Pentazocine / Q000494:pharmacology*; D011149:Pons / Q000378:metabolism; D051381:Rats; D012044:Regression Analysis
D018492:Dopamine Antagonists; D008781:Methyltyrosines; D009270:Naloxone; D009020:Morphine; D010423:Pentazocine; D004298:Dopamine; D009638:Norepinephrine